Dr. Ali Kemal Belviranlı Obstetrics and Children's Hospital, Konya, Turkey.
Department of Family Medicine, Konya City Hospital, Konya, Turkey.
Pediatr Neonatol. 2023 Jan;64(1):38-45. doi: 10.1016/j.pedneo.2022.04.014. Epub 2022 Aug 24.
IgG subclass deficiency is a laboratory diagnosis and becomes important with recurrent infections. This study aimed to examine the demographic, clinical, and laboratory results of pediatric cases with IgG subclass deficiency and to improve the understanding of the clinical significance of IgG subclass deficiency.
In this study, the clinical and laboratory features of 111 pediatric patients, with at least one whose serum IgG subclasses was measured as lower than 2 standard deviation of healthy aged-matched control values, were evaluated. The clinical and laboratory features of the cases with isolated IgG subclass deficiency (Group 1) and those with low serum levels of any of IgG, IgA, and IgM in addition to the IgG subclass deficiency (Group 2) were compared.
A total of 55 (49.54%) and 56 (50.45%) patients were included in Groups 1 and 2, respectively. Among our studied cases, 20 (18.1%) had a history of hospitalization in the neonatal period, 61 (54.95%) had at least one hospitalization due to infection, and 55 (49.54%) had a history of recurrent infection. The frequencies of these three conditions were statistically significantly higher in Group 2 (p < 0.05). The frequencies of infections in the last year in Groups 1 and 2 were 4.4 ± 1.2 and 5.4 ± 1.9, respectively (p < 0.05). As a result of recurrent infections, 43.24% (n = 48) of our patients received antibiotic prophylaxis, and 21.62% (n = 24) had immunoglobulin replacement therapy. Furthermore, the numbers of patients who needed these treatments were higher in Group 2 (p < 0.05).
In cases with IgG subclass deficiencies, concomitant main-group immunoglobulin deficiencies may increase the number and severity of infections, leading to hospitalizations, antibiotic prophylaxis, and immunoglobulin therapy. More attention should be paid to cases of immunoglobulin main-group deficiencies in the follow-up of these cases.
IgG 亚类缺陷是一种实验室诊断,在反复感染时变得尤为重要。本研究旨在研究患有 IgG 亚类缺陷的儿科病例的人口统计学、临床和实验室结果,以提高对 IgG 亚类缺陷临床意义的认识。
本研究评估了 111 例儿科患者的临床和实验室特征,其中至少有 1 例患者的血清 IgG 亚类低于健康年龄匹配对照值的 2 个标准差。比较了单纯 IgG 亚类缺陷(第 1 组)和除 IgG 亚类缺陷外还伴有血清 IgG、IgA 和 IgM 任何一种水平降低的病例(第 2 组)的临床和实验室特征。
共有 55 例(49.54%)和 56 例(50.45%)患者分别纳入第 1 组和第 2 组。在我们研究的病例中,20 例(18.1%)有新生儿期住院史,61 例(54.95%)因感染至少住院一次,55 例(49.54%)有反复感染史。第 2 组这三种情况的频率均显著高于第 1 组(p<0.05)。第 1 组和第 2 组去年的感染频率分别为 4.4±1.2 和 5.4±1.9(p<0.05)。由于反复感染,我们的 43.24%(n=48)患者接受了抗生素预防治疗,21.62%(n=24)接受了免疫球蛋白替代治疗。此外,第 2 组需要这些治疗的患者数量更多(p<0.05)。
在 IgG 亚类缺陷患者中,同时存在主要免疫球蛋白缺陷可能会增加感染的数量和严重程度,导致住院、抗生素预防和免疫球蛋白治疗。在对这些患者进行随访时,应更加关注主要免疫球蛋白缺陷的病例。